Polymers imbedded with non-steroidal immunosuppressive drugs, such as cyclosporine A and anti-TNF are in development and could provide an excellent alternative to the current sustained release corticosteroid delivery devices available for the treatment of uveitis and other ocular disease [88]. Here, TNF is linked to uveitis.